Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Amarin Corp ADR (NQ: AMRN ) 0.5801 +0.0101 (+1.77%) Streaming Delayed Price Updated: 4:00 PM EDT, Oct 18, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Amarin Corp ADR < Previous 1 2 ... 4 5 6 7 8 9 10 11 Next > Why Amarin Stock Is Tumbling Today May 12, 2021 An analyst downgraded the drugmaker. Via The Motley Fool Benzinga's Top Ratings Upgrades, Downgrades For May 12, 2021 May 12, 2021 Upgrades Craig-Hallum upgraded the previous rating for ShotSpotter Inc (NASDAQ:SSTI) from Hold to Buy. For the first quarter, ShotSpotter had an EPS of $0.02, compared to... Via Benzinga 10 Biggest Price Target Changes For Wednesday May 12, 2021 HC Wainwright & Co. lowered Novavax, Inc. (NASDAQ: NVAX) price target from $317 to $294. Novavax shares fell 1.6% to $136.00 in pre-market trading. Needham cut BigCommerce... Via Benzinga Amarin (AMRN) Q1 2021 Earnings Call Transcript April 29, 2021 AMRN earnings call for the period ending March 31, 2021. Via The Motley Fool Topics Earnings Exposures Financial The Daily Biotech Pulse: Clinical Setback For Adverum, Galera Posts Data Readout, Moderna To Invest In Vaccine Manufacturing, Decision Day For Ardelyx April 29, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 28) Axonics, Inc. (NASDAQ:... Via Benzinga Amarin: Q1 Earnings Insights April 29, 2021 Shares of Amarin Corp (NASDAQ:AMRN) rose 2.5% in pre-market trading after the company reported Q1 results. Quarterly Results Earnings per share rose 100.00% over the past... Via Benzinga The Week Ahead In Biotech (April 25-May 1): FDA Decisions For Sol-Gel, Protalix Bio, Ardelyx April 24, 2021 Biopharma stocks came back from the weakness seen in the first two sessions to close the week ended April 23 higher. Johnson & Johnson (NYSE: JNJ) and Roche Holding AG (OTC:... Via Benzinga Exposures Product Safety Cramer Weighs In On Paysafe, Xilinx And More April 15, 2021 On CNBC's "Mad Money Lightning Round," Jim Cramer said Keysight Technologies Inc (NYSE: KEYS) has been just red hot and he really likes it. Amarin Corporation plc (... Via Benzinga 50 Biggest Movers From Yesterday April 14, 2021 Gainers Mackinac Financial Corporation (NASDAQ: MFNC) shares surged 60.7% to close at $21.16 on Tuesday after the company, and Nicolet Bankshares, jointly announced the execution... Via Benzinga 12 Health Care Stocks Moving In Tuesday's Intraday Session April 13, 2021 Gainers NovoCure (NASDAQ:NVCR) shares rose 42.08% to $187.38 during Tuesday's regular session. Trading volume for NovoCure's stock is 11.4 million as of 12:32 EST... Via Benzinga Why Amarin Stock Is Sinking Today April 13, 2021 The company's CEO announced his retirement. Via The Motley Fool The Daily Biotech Pulse: Leadership Transition At Amarin, Vaccine Setback For J&J, FDA Nod For Label Expansion of Roche's Asthma Drug April 13, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 12) 180 Life Sciences Corp. (... Via Benzinga Exposures Product Safety Should You Buy Amarin in April? April 09, 2021 This biotech's heart medication could be wildly lucrative. Via The Motley Fool < Previous 1 2 ... 4 5 6 7 8 9 10 11 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.